$1.98
0.126.45%
Last update: Nov 10, 5:00 PM
NeuroSense Therapeutics Ltd
NRSNNASDAQ
NeuroSense Therapeutics rose 96.6% from $0.95 to $1.86, ahead of the S&P 500's +10.0%. Its worst day was Nov 2 (−28.1%), and its low came Sep 10 at $0.33.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-8.80 missed the $-8.00 estimate on $0.00 revenue.
+3.3% · S&P 500 +2.9%
NeuroSense Therapeutics closed at its lowest level of the year, 64.9% below where the year started.
Story events cover the past 12 months · Times ET
−17.2% · S&P 500 −0.6%
EPS of $-2.10 missed the $-0.08 estimate on $0.00 revenue (est. $514,000.00).
−0.7% · S&P 500 +0.5%
Where it ended: a close of $1.86 on Nov 9, 2026.
Nothing in the past 12 months.
All NRSN dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for NRSN and SPY from Benzinga historical bars. Not investment advice.
